New study highlights that opioid dose variability may be a significant risk factor for opioid overdose. The findings of the study are published in the journal JAMA Network Open.
Patients prescribed opioid pain medications whose doses varied over time were 3 times more likely to experience an overdose than patients prescribed stable opioid doses, according to an observational study from Kaiser Permanente. The study also showed that patients who discontinued long-term opioid therapy for 3 or more months had half the risk of opioid overdose.
Investigational Drug Has Potential to Treat Opioid Withdrawal Symptoms
Rapastinel, the new experimental drug, could be useful to help manage opioid withdrawal during the initial days after someone has entered treatment and is trying to abstain from opioid use.
Advertisement
‘Patients prescribed opioid pain medications whose doses varied over time were more likely to experience an overdose.’
Tweet it Now
"Our study suggests that safely managing long-term opioid therapy is complex," said Ingrid Binswanger, MD, a senior investigator at Kaiser Permanente Institute for Health Research in Colorado and co-author of the study.
"This study suggests going up and down on opioid doses -- also called dose variability -- could present an increased risk of overdose," Dr. Binswanger said. "Through this study, we also found eventually discontinuing opioid therapy may prevent overdoses. With continued studies, we hope to find out how care providers can help patients with their pain without putting them at unnecessary risk due to rapid changes in their dose."
![First Ever Smartphone App to Identify Opioid Overdose]( "First Ever Smartphone App to Identify Opioid Overdose")
First ever smartphone App dubbed SecondChance can accurately identify opioid overdose by monitoring a person's breathing and movement and helps save the person's life.
The 12-year study included more than 14,000 Kaiser Permanente members in Colorado who were prescribed long-term opioids. Researchers used electronic health records to track the history of patients to see if they had dose changes and overdoses from opioid pain medications and other opioid drugs.
The research team obtained a follow-up $2 million, 4-year grant from the National Institutes for Health. The study will look at how patients and doctors manage changes in opioid doses, including any long-term risks and benefits of discontinuing opioid pain medications.
"Kaiser Permanente, like many health care organizations across the country, has made significant changes to safely reduce opioid prescriptions for our members," said Jason Glanz, Ph.D., a senior investigator at the Institute for Health Research and co-author on the study.
"This study represents the first of many investigations that we plan to do on the topic," Dr. Glanz said. "Our goal is to help identify the most safe and effective approaches for managing long-term opioid therapy. We want to be able to minimize patients' pain and reduce their risk for overdose."
Source: Eurekalert
First Ever Smartphone App to Identify Opioid Overdose
First ever smartphone App dubbed SecondChance can accurately identify opioid overdose by monitoring a person's breathing and movement and helps save the person's life.
Advertisement
The 12-year study included more than 14,000 Kaiser Permanente members in Colorado who were prescribed long-term opioids. Researchers used electronic health records to track the history of patients to see if they had dose changes and overdoses from opioid pain medications and other opioid drugs.
The research team obtained a follow-up $2 million, 4-year grant from the National Institutes for Health. The study will look at how patients and doctors manage changes in opioid doses, including any long-term risks and benefits of discontinuing opioid pain medications.
"Kaiser Permanente, like many health care organizations across the country, has made significant changes to safely reduce opioid prescriptions for our members," said Jason Glanz, Ph.D., a senior investigator at the Institute for Health Research and co-author on the study.
"This study represents the first of many investigations that we plan to do on the topic," Dr. Glanz said. "Our goal is to help identify the most safe and effective approaches for managing long-term opioid therapy. We want to be able to minimize patients' pain and reduce their risk for overdose."
Source: Eurekalert
Does The One-Hour Discharge Rule After Opioid Overdose Still Stand?
After the naloxone, people with opioid overdose can be discharged, says the study. The one hour rule still stands.
Advertisement
 New Model to Predict Opioid Overdose Risk DevelopedNew model predicts the risk of opioid overdose among Medicare beneficiaries with at least one opioid prescription. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The CDSCO has approved the intravenous administration of AstraZeneca Pharma India's liver cancer drug, Tremelimumab Concentrate.
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.